202 related articles for article (PubMed ID: 29966512)
1. Phosphate binders as a cause of hypothyroidism in dialysis patients: practical indications from a review of the literature.
Cataldo E; Columbano V; Nielsen L; Gendrot L; Covella B; Piccoli GB
BMC Nephrol; 2018 Jul; 19(1):155. PubMed ID: 29966512
[TBL] [Abstract][Full Text] [Related]
2. Sevelamer carbonate markedly reduces levothyroxine absorption.
Iovino M; Iovine N; Petrosino A; Giagulli VA; Licchelli B; Guastamacchia E; Triggiani V
Endocr Metab Immune Disord Drug Targets; 2014; 14(3):206-9. PubMed ID: 25183496
[TBL] [Abstract][Full Text] [Related]
3. Effect of phosphate binders upon TSH and L-thyroxine dose in patients on thyroid replacement.
Diskin CJ; Stokes TJ; Dansby LM; Radcliff L; Carter TB
Int Urol Nephrol; 2007; 39(2):599-602. PubMed ID: 17216296
[TBL] [Abstract][Full Text] [Related]
4. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
5. Pseudomalabsorption of levothyroxine: a case report.
Ogawa D; Otsuka F; Mimura U; Ueno A; Hashimoto H; Kishida M; Ogura T; Makino H
Endocr J; 2000 Feb; 47(1):45-50. PubMed ID: 10811292
[TBL] [Abstract][Full Text] [Related]
6. Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD).
Ruospo M; Palmer SC; Natale P; Craig JC; Vecchio M; Elder GJ; Strippoli GF
Cochrane Database Syst Rev; 2018 Aug; 8(8):CD006023. PubMed ID: 30132304
[TBL] [Abstract][Full Text] [Related]
7. Initiation of Sevelamer and Mortality among Hemodialysis Patients Treated with Calcium-Based Phosphate Binders.
Komaba H; Wang M; Taniguchi M; Yamamoto S; Nomura T; Schaubel DE; Smith AR; Zee J; Karaboyas A; Bieber B; Fukagawa M; Tentori F
Clin J Am Soc Nephrol; 2017 Sep; 12(9):1489-1497. PubMed ID: 28724618
[TBL] [Abstract][Full Text] [Related]
8. Exaggerated levothyroxine malabsorption due to calcium carbonate supplementation in gastrointestinal disorders.
Csako G; McGriff NJ; Rotman-Pikielny P; Sarlis NJ; Pucino F
Ann Pharmacother; 2001 Dec; 35(12):1578-83. PubMed ID: 11793625
[TBL] [Abstract][Full Text] [Related]
9. A Prospective Study to Evaluate the Possible Role of Cholecalciferol Supplementation on Autoimmunity in Hashimoto's Thyroiditis.
Bhakat B; Pal J; Das S; Charaborty SK; SircarMedical NR; Kolkata ; RGKar ; NorthBengal ; Siliguri
J Assoc Physicians India; 2023 Jan; 71(1):1. PubMed ID: 37116030
[TBL] [Abstract][Full Text] [Related]
10. Hypothyroidism in adults. Levothyroxine if warranted by clinical and laboratory findings, not for simple TSH elevation.
Prescrire Int; 2015 Oct; 24(164):241-4, 246. PubMed ID: 26594730
[TBL] [Abstract][Full Text] [Related]
11. Effect of calcium carbonate on the absorption of levothyroxine.
Singh N; Singh PN; Hershman JM
JAMA; 2000 Jun; 283(21):2822-5. PubMed ID: 10838651
[TBL] [Abstract][Full Text] [Related]
12. Is Parenteral Levothyroxine Therapy Safe in Intractable Hypothyroidism?
Peynirci H; Taskiran B; Erturk E; Sisman P; Ersoy C
J Natl Med Assoc; 2018 Jun; 110(3):245-249. PubMed ID: 29778126
[TBL] [Abstract][Full Text] [Related]
13. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
14. Increased thyroid-stimulating hormone levels associated with concomitant administration of levothyroxine and raloxifene.
Garwood CL; Van Schepen KA; McDonough RP; Sullivan AL
Pharmacotherapy; 2006 Jun; 26(6):881-5. PubMed ID: 16716142
[TBL] [Abstract][Full Text] [Related]
15. Effect of Calcium-based Phosphate Binders Versus Sevelamer on Mortality of Patients with Hemodialysis: A Meta-analysis.
Zhang P; Sang S; Huang J; Feng S; Feng C; Wang R
Iran J Kidney Dis; 2022 Jul; 16(4):215-227. PubMed ID: 35962636
[TBL] [Abstract][Full Text] [Related]
16. Hypothyroidism in the elderly: pathophysiology, diagnosis and treatment.
Laurberg P; Andersen S; Bülow Pedersen I; Carlé A
Drugs Aging; 2005; 22(1):23-38. PubMed ID: 15663347
[TBL] [Abstract][Full Text] [Related]
17. Differences in gastrointestinal calcium absorption after the ingestion of calcium-free phosphate binders.
Behets GJ; Dams G; Damment SJ; Martin P; De Broe ME; D'Haese PC
Am J Physiol Renal Physiol; 2014 Jan; 306(1):F61-7. PubMed ID: 24197066
[TBL] [Abstract][Full Text] [Related]
18. Probable interaction between levothyroxine and ritonavir: Case report and literature review.
Sahajpal R; Ahmed RA; Hughes CA; Foisy MM
Am J Health Syst Pharm; 2017 Apr; 74(8):587-592. PubMed ID: 28389458
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of morbidity and mortality data related to cardiovascular calcification from calcium-containing phosphate binder use in patients undergoing hemodialysis.
Mason MA; Shepler BM
Pharmacotherapy; 2010 Jul; 30(7):741-8. PubMed ID: 20575637
[TBL] [Abstract][Full Text] [Related]
20. Effects and safety of iron-based phosphate binders in dialysis patients: a systematic review and meta-analysis.
Zhai CJ; Yu XS; Yang XW; Sun J; Wang R
Ren Fail; 2015 Feb; 37(1):7-15. PubMed ID: 25350834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
